Variant report
Variant | esv3501887 |
---|---|
Chromosome Location | chr6:144453229-144453854 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77794624 | chr6:144453236-144453237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534132091 | chr6:144453238-144453239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs118128898 | chr6:144453262-144453263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567968816 | chr6:144453270-144453271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545834740 | chr6:144453309-144453310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180869060 | chr6:144453320-144453321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537815990 | chr6:144453321-144453322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556502947 | chr6:144453341-144453342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186062875 | chr6:144453362-144453363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539135395 | chr6:144453368-144453369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375027974 | chr6:144453419-144453420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559190064 | chr6:144453441-144453442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35997492 | chr6:144453446-144453447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13220400 | chr6:144453535-144453536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13220402 | chr6:144453540-144453541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11758194 | chr6:144453618-144453619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9496875 | chr6:144453626-144453627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9403550 | chr6:144453661-144453662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572232977 | chr6:144453689-144453690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531224663 | chr6:144453694-144453695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199555998 | chr6:144453699-144453700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561140164 | chr6:144453726-144453727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576302396 | chr6:144453735-144453736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543386688 | chr6:144453768-144453769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113724413 | chr6:144453801-144453802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551345178 | chr6:144453818-144453819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181416920 | chr6:144453829-144453830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:144451200-144460400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr6:144452400-144456200 | Weak transcription | NHLF | lung |
3 | chr6:144453000-144454600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr6:144453000-144455200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr6:144453000-144455200 | Weak transcription | NHDF-Ad | bronchial |
6 | chr6:144453000-144455200 | Weak transcription | Osteobl | bone |
7 | chr6:144453000-144458800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr6:144453200-144453600 | Weak transcription | HUVEC | blood vessel |
9 | chr6:144453200-144455200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
10 | chr6:144453200-144455400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr6:144453600-144456200 | Enhancers | HUVEC | blood vessel |